HOME >> BIOLOGY >> NEWS
Women pregnant with girls experience more severe asthma symptoms

Women with asthma who are carrying a female fetus are more likely to experience worse asthma symptoms than asthmatic women carrying a male fetus, researchers at Yale School of Medicine report in the February issue of American Journal of Epidemiology.

"This is one of the first and largest studies to investigate the effect of fetal sex on the severity of the mother's asthma, and one of the largest to investigate the effect of fetal sex on any disease of the mother," said senior author Michael B. Bracken, Susan Dwight Bliss Professor of Epidemiology in the Department of Epidemiology and Public Health at Yale School of Medicine.

The researchers monitored 702 pregnant women throughout southern New England who were trained to assess their lung function for 10-day intervals at selected points in pregnancy. Lung function and a large number of other factors that might influence severity of the mother's asthma were recorded automatically.

Asthma worsened in mothers with either male or female fetuses until about 30 weeks gestation, after which there was an improvement in lung function. However, throughout pregnancy, mothers with a male fetus had 10 percent better lung function.

"This difference due to sex is potentially important but needs to be placed in the context of other factors which have a greater impact on the severity of mother's asthma, including inadequate medical management of asthma symptoms, and whether the mother was a smoker or not," said Bracken, who also co-directs the Yale Center for Perinatal, Pediatric and Environmental Epidemiology.

The authors speculate that testosterone, secreted by the male fetuses, may relax the mother's bronchial tissue and inhibit response to histamines. Other sex-specific factors excreted by female fetuses may aggravate inflammation in mothers. Bracken said more research is needed to test these hypotheses.

Asthma is one of the most common diseases associated with pregnancy. An up
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
2-Feb-2006


Page: 1 2

Related biology news :

1. Women up to age 30 at risk for bone loss, study finds
2. MBL scientist Julie Huber receives 2007 LOral USA Fellowship for Women in Science
3. Brandeis and Brigham and Womens Hospital license technology for Gauchers to Amicus Therapeutics
4. Women in polluted areas at higher risk of cardiovascular disease
5. Womens skin tone influences perception of beauty, health and age
6. Womens math performance affected by theories on sex differences: UBC researchers
7. Womens Bioethics Project unveils The Scientist & the Ethicist podcast series
8. Weizmann Women & Science Award presented to Dr. Mary-Claire King
9. Mary-Claire King to receive the 2006 Weizmann Women & Science Award
10. Womens health findings presented at national conference
11. Womens bioethics project receives grant from Ford Foundation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Women pregnant with girls experience more severe asthma symptoms

(Date:12/3/2014)... 2, 2014   Marvin Test Solutions , ... solutions for military, aerospace, and manufacturing organizations, today ... successful TS-900 PXI semiconductor test platform . ... high-end systems to customers at a fraction of ... traditional ATE. "Our semiconductor customers ...
(Date:11/21/2014)... Nov. 19, 2014  Earlier this year Donald ... College, and one of the most prolific inventors in ... are transmitted from Smartphones to third party agencies. Spector ... has one of the earliest known patents in this ... in the military, child care, elder care and hospital ...
(Date:11/21/2014)... Calif. , Nov. 20, 2014   Atmel® ... leader in microcontroller (MCU) and touch technology solutions, today ... temperature sensors with the widest V cc ... higher temperature accuracy and faster I 2 C bus ... and serial EEPROM memory making them ideal for consumer, ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: